Guru Fundamental Report for HIMS

Validea's guru fundamental report indicates that HIMS & HERS HEALTH INC (HIMS) receives a 75% rating based on their Small-Cap Growth Investor model, which is based on the Motley Fool strategy that favors small-cap growth stocks with solid fundamentals and strong price performance; the report highlights several strengths including profit margin, relative strength, sales and EPS growth, and insider holdings, but also points out failures in cash and cash equivalents, the Fool Ratio, average shares outstanding, sales, and daily dollar volume.

Analysis

HIMS & HERS HEALTH INC (HIMS), a large-cap growth stock in the Biotechnology & Drugs sector, received a 75% rating from Validea's Small-Cap Growth Investor model, a strategy based on Motley Fool principles that targets small-cap growth stocks with robust fundamentals and strong price performance. This score is below the 80% threshold typically indicating strategy interest. The analysis highlights several fundamental strengths for HIMS, as it passed criteria for Profit Margin, Relative Strength, year-over-year Sales and EPS Growth comparison, Insider Holdings, Cash Flow From Operations, Profit Margin Consistency, R&D as a Percentage of Sales, Inventory to Sales, Accounts Receivable to Sales, Long Term Debt/Equity Ratio, and Price. However, the report also flags notable weaknesses: HIMS failed criteria related to Cash and Cash Equivalents, "The Fool Ratio" (P/E to Growth), Average Shares Outstanding, absolute Sales level (distinct from its growth rate), Daily Dollar Volume, and Income Tax Percentage. The presence of these failed metrics, particularly concerning cash levels, valuation relative to growth, and share count, indicates specific areas of concern despite the positive indicators in operational efficiency and market momentum.

Key Decisions for Investors

• Investors should note the mixed assessment; while HIMS shows strength in several fundamental areas like profit margins and growth metrics, the 75% score from the Small-Cap Growth model is moderate and below the typical 'interest' threshold, warranting careful consideration.
• Particular attention should be paid to the 'FAIL' ratings on 'Cash and Cash Equivalents', 'The Fool Ratio' (P/E to Growth), 'Average Shares Outstanding', and 'Daily Dollar Volume', as these factors can impact liquidity, valuation attractiveness, and potential shareholder dilution.
• Given HIMS is a large-cap stock evaluated by a small-cap model, investors should further investigate if the strategy's criteria for 'Sales' (absolute level) and 'Daily Dollar Volume' are appropriate benchmarks or if these failures indicate specific risks for a company of HIMS's scale.